Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study

NCT00002757 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
October 31, 2009
Enrollment
1,148 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma